Purchase Order 75N90025P00514
- Not listed
- The NIH Clinical Center awarded a $25,624.35 firm fixed price purchase order to Bionano Genomics, Inc. for the procurement of reagents to support optical genome mapping experiments. The contract, which was awarded on September 19, 2025, with an ultimate completion date of September 18, 2026, includes no small business set-aside designation. Bionano Genomics, a San Diego-based manufacturer specializing in advanced genomic analysis solutions, will provide consumable materials and reagents...
- Bionano Genomics, Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services' National Institutes of Health Clinical Center worth $68,747.30 to supply BIONANO PREP SP-G2 BMA 12 GENOME BUNDLE, G3.3 KITS. The kits include consumables to map 12 human genomes and will support the NIH Clinical Center's genomic research efforts. Performance will take place in San Diego, California by March 2024. No subcontractors or set-aside designation were specified....
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $16,875 firm fixed price purchase order to Bionano Genomics, Inc. to deliver NEXUS COPY NUMBER DISCOVERY services for one year. The contract will support the NIH National Human Genome Research Institute's genomic research efforts through Bionano Genomics' single-molecule optical mapping technology, which enables structural variant detection and advanced genome analysis....
- The National Institutes of Health (NIH) Clinical Center awarded a $120,000.00 firm-fixed price purchase order to Bionano Genomics, Inc., a for-profit manufacturer of goods, for the buyout of a proprietary Saphyr System Bionano Optical Genome Mapping (OGM) instrument. This sole-source acquisition is being conducted under the Simplified Acquisition Procedures in Federal Acquisition Regulation (FAR) Part 13, as the total value does not exceed the $250,000.00 Simplified Acquisition Threshold. The...
- This federal contract award is for Bionano Genomics, Inc. to provide a license renewal for the Nexus Copy Number software to the National Human Genome Research Institute (NHGRI). The $16,875 firm fixed-price purchase order supports NHGRI's genomics research initiatives, allowing the agency to analyze genotype data using Bionano's advanced genomic analysis technology. Bionano Genomics is a for-profit manufacturer of scientific instruments and consumables for genetic research, with a history of...
- This is a firm fixed-price delivery order contract awarded to Illumina, Inc., a biotechnology company headquartered in San Diego, California. The $12,836.50 contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, on September 24, 2025 with an ultimate completion date of October 23, 2025. The contract does not utilize any set-aside designations. Illumina, a for-profit manufacturer of goods, will provide the NIH with various genomic sequencing...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $48,209 purchase order to Illumina, Inc. of Bethesda, Maryland. The contract is to provide products or services to NIH under contract number 1107104 from September 13, 2023 through September 12, 2024. As the prime contractor, Illumina will supply genomic sequencing equipment, reagents, or related services to support NIH's biomedical research efforts. No...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc. for genomic analysis products and services. The $15,000.00 contract has a period of performance through July 2025 and does not have a set-aside designation. 10X Genomics is providing specialized kits, instruments, and related support services for single-cell and spatial analysis applications to support biomedical research efforts, primarily for the NIH and its...
- The Department of Health and Human Services' National Institutes of Health (NIH) awarded a $46,411.00 firm fixed price purchase order to 10X Genomics, Inc., a small business that specializes in life sciences technology, to provide reagent kits. The award has a completion date of August 21, 2020. 10X Genomics previously held an indefinite delivery contract valued up to $750,000 with the NIH's National Institute of Neurological Disorders and Stroke to supply optimization slides, reagent kits,...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The purpose of this $15,550.20 contract is to provide 10X Genomics optimization...
Bionano Genomics, Inc. was awarded a $24,115.32 firm fixed-price purchase order by the National Institutes of Health (NIH) Clinical Center on June 12, 2025, with an ultimate completion date of July 17, 2025. This contract, issued without a small business set-aside designation, represents a direct procurement of genomic research materials or equipment from the San Diego-based manufacturer. The award leverages the company's established expertise in optical genome mapping technology and consumable kits that support advanced genetic research and diagnostics across federal research institutions. The NIH Clinical Center, the research hospital of the National Institutes of Health, pursues this procurement as part of its ongoing commitment to cutting-edge biomedical research and clinical diagnostics. Bionano Genomics has a demonstrated track record of supporting federal genomic research initiatives, with prior contracts across multiple NIH entities and civilian agencies focused on procuring specialized instruments such as the Saphyr System and associated genome mapping supplies. This purchase order contributes to the Clinical Center's capabilities in structural variant detection and genetic analysis that inform critical research in areas including cancer and hematological conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 6/18/25 |